HighTower Advisors
MEDP icon

HighTower Advisors’s Medpace MEDP Stock Holding History

HighTower Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Sell
3,699
-983
-21% -$454K ﹤0.01% 1795
2026
Q1 		$2.25M Sell
4,682
-771
-14% -$395K ﹤0.01% 1647
2025
Q4 		$3.06M Buy
5,453
+1,476
+37% +$838K ﹤0.01% 1438
2025
Q3 		$2.04M Sell
3,977
-829
-17% -$362K ﹤0.01% 1623
2025
Q2 		$1.51M Buy
4,806
+1,618
+51% +$486K ﹤0.01% 1739
2025
Q1 		$971K Buy
3,188
+48
+2% +$16.1K ﹤0.01% 1984
2024
Q4 		$1.04M Buy
3,140
+142
+5% +$48.2K ﹤0.01% 1930
2024
Q3 		$999K Sell
2,998
-5,343
-64% -$2.03M ﹤0.01% 1930
2024
Q2 		$3.42M Buy
8,341
+4,786
+135% +$1.9M 0.01% 1169
2024
Q1 		$1.43M Buy
3,555
+159
+5% +$55.9K ﹤0.01% 1598
2023
Q4 		$1.07M Buy
3,396
+377
+12% +$102K ﹤0.01% 1815
2023
Q3 		$713K Sell
3,019
-93
-3% -$23.8K ﹤0.01% 1979
2023
Q2 		$735K Buy
3,112
+477
+18% +$99.1K ﹤0.01% 1941
2023
Q1 		$507K Sell
2,635
-562
-18% -$116K ﹤0.01% 2098
2022
Q4 		$676K Sell
3,197
-277
-8% -$55.3K ﹤0.01% 1919
2022
Q3 		$538K Sell
3,474
-321
-8% -$51.2K ﹤0.01% 1976
2022
Q2 		$555K Buy
+3,795
New +$549K ﹤0.01% 1984
2022
Q1 		– Sell
-2,293
Closed -$499K – 3567
2021
Q4 		$499K Sell
2,293
-36
-2% -$7.54K ﹤0.01% 2161
2021
Q3 		$439K Buy
2,329
+26
+1% +$4.74K ﹤0.01% 2142
2021
Q2 		$403K Buy
2,303
+67
+3% +$11.6K ﹤0.01% 2170
2021
Q1 		$362K Buy
2,236
+285
+15% +$43.6K ﹤0.01% 2165
2020
Q4 		$271K Buy
+1,951
New +$246K ﹤0.01% 2002
2019
Q4 		– Sell
-9,314
Closed -$783K – 2475
2019
Q3 		$783K Buy
+9,314
New +$704K ﹤0.01% 1293

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

HighTower Advisors's MEDP Position: Q2 2026 in Review

HighTower Advisors reduced its Medpace (MEDP) stake by 21% in Q2 2026, selling an estimated $454K and leaving 3,699 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

HighTower Advisors first reported a position in MEDP in Q3 2019 and has held it in 23 quarters since. The position peaked at $3.42M in Q2 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • HighTower Advisors held 3,699 shares of Medpace worth $1.96M as of Q2 2026.
  • HighTower Advisors sold 983 Medpace shares in Q2 2026, an estimated $454K.
  • Medpace made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1795 holding.
  • HighTower Advisors first reported a position in Medpace in Q3 2019 and has held it in 23 quarters since.
  • HighTower Advisors's Medpace position peaked at $3.42M in Q2 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.